Research and Markets: The Global Aptamers Market was Valued at $287 Million in 2013 and is Expected to Reach $2.1 Billion by 2018
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/qfxndn/aptamers_market) has announced the addition of the "Aptamers Market Technology Trend Analysis - Global Forecasts to 2018" report to their offering.
“Aptamers Market Technology Trend Analysis - Global Forecasts to 2018”
The global aptamers market is anticipated to reach $2.1 billion by 2018 growing at a CAGR of 49.24%. The aptamers market is divided by geography (North America, Europe, Asia-Pacific and Rest of the World), application segments (therapeutics, diagnostics, biosensors, drug discovery, biomarker discovery, and research applications) and aptamer type (Nucleic acid aptamers and Peptide aptamers). Further each application segment and the aptamer type is broken down by geography, with exhaustive revenue analysis for the entire forecast period. Of the above mentioned application segments, research applications is the largest revenue segment; however, biomarker discovery and diagnostics will be the fastest-growing segment.
The potential growth of the market is attributed to future diagnostics, drug discovery and research applications. The future approval of a few diagnostic tests specifically for infectious diseases and a couple of drugs in the market will greatly propel the market. The global market for aptamers is expected to grow, backed by technological advancements with respect to selection processes and synthesis. The market will experience continuous improvements in aptamer synthesis and its applicability in drug discovery and routine research. The market is witnessing a trend toward development of personalized medicine and point-of-care diagnostic tests. Additionally, the demand for safe and cost-effective drugs for treatment of cancer (which can be fulfilled by aptamer therapeutics), will remarkably fuel market growth.
- AM Biotechnologies, Llc
- Aptagen, LIC
- Aptamatrix, Inc
- Aptamer Sciences Inc
- Aptamer Solutions Ltd
- Aptares AG
- Base Pair Biotechnologies
- Bioapter SL
- Cd Genomics
- Integrated Dna Technologies, Inc
- Lucerna, Inc
- NOXXON Pharma AG
- Neoventures Biotechnology Inc
- OTC Biotech
- Ophthotech Corporation
- Regado Biosciences, Inc
- Somalogic, Inc
- Trilink Biotechnologies, Inc
For more information visit http://www.researchandmarkets.com/research/qfxndn/aptamers_market.
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.